Letter to FDA: ILR Request to Participate Share page: Docket Number: FDA-2015-N-0001 Please accept this letter as an official request from the CHPA to participate in the selection process for nonvoting industry representatives for several public advisory committees for the Center for Drug Research & Evaluation. Download Document Issues: OTC Medicines Related Posts Press Releases and Statements House Leaders Prioritize OMUFA Renewal, CHPA Welcomes Progress Apr 1, 2025 Press Releases and Statements CHPA Statement on Senate Confirmation of Dr. Makary as FDA Commissioner Mar 25, 2025 Press Releases and Statements CHPA Applauds New Mississippi Law to Prevent Unlawful Purchases of PSE-Containing Medicines Mar 21, 2025